Seagen Inc. (SGEN) Q3 2022 Earnings Conference Call October 27, 2022 4:30 PM ET
Company Participants
Doug Maffei - Vice President, Investor Relations
Roger Dansey - Interim Chief Executive Officer and Chief Medical Officer
Todd Simpson - Chief Financial Officer
Chip Romp - Executive Vice President, Commercial U.S.
Conference Call Participants
Michael Schmidt - Guggenheim
Andrew Berens - SVB Securities
Jeff Hung - Morgan Stanley
Jay Olson - Oppenheimer
Gregory Renza - RBC Capital Markets
Andy Hsieh - William Blair
Operator
Good day and welcome to the Seagen Third Quarter 2022 Financial Results Conference Call. [Operator Instructions] Please note, today’s event is being recorded. I would now like to turn the conference over to Doug Maffei, Vice President, Investor Relations. Please go ahead.
Doug Maffei
Thank you, operator and good afternoon everyone. I am pleased to welcome you to Seagen’s third quarter 2022 financial results conference call. This afternoon, we issued a press release with our results. The press release and supporting slides are available on our website in the Investors section, Events & Presentations page.
Speakers on today’s call will be Roger Dansey, Interim Chief Executive Officer and Chief Medical Officer; Todd Simpson, Chief Financial Officer; and Chip Romp, Executive Vice President, Commercial U.S. Following our prepared remarks, we will open the line for questions. We aim to keep this call to 1 hour and ask that you limit yourself to one question to give everyone an opportunity to participate in Q&A during our call today.
Today’s conference call will include forward-looking statements regarding future or anticipated events and results, including the company’s 2022 financial outlook, anticipated product sales, revenues, costs and expenses; potential clinical and regulatory milestones, including data readouts and regulatory submissions, potential marketing approvals and commercial performance.
Actual results or developments may differ materially from those
- Read more current SGEN analysis and news
- View all earnings call transcripts